<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.sciencedaily.com/~d/styles/itemcontent.css"?><rss xmlns:media="http://search.yahoo.com/mrss/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
	<channel>
		<title>Ovarian Cancer News -- ScienceDaily</title>
		<link>https://www.sciencedaily.com/news/health_medicine/ovarian_cancer/</link>
		<description>Information about ovarian cancer symptoms and treatments. Explore the latest medical research on ovarian cysts and ovarian cancer including including stages of the disease and new treatment options.</description>
		<language>en-us</language>
		<pubDate>Sun, 06 Mar 2016 23:07:58 EST</pubDate>
		<lastBuildDate>Sun, 06 Mar 2016 23:07:58 EST</lastBuildDate>
		<ttl>60</ttl>
		<image>
			<title>Ovarian Cancer News -- ScienceDaily</title>
			<url>https://www.sciencedaily.com/images/scidaily-logo-rss.png</url>
			<link>https://www.sciencedaily.com/news/health_medicine/ovarian_cancer/</link>
			<description>For more science news, visit ScienceDaily.</description>
		</image>
		
		<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.sciencedaily.com/sciencedaily/health_medicine/ovarian_cancer" /><feedburner:info uri="sciencedaily/health_medicine/ovarian_cancer" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:emailServiceId>sciencedaily/health_medicine/ovarian_cancer</feedburner:emailServiceId><feedburner:feedburnerHostname>https://feedburner.google.com</feedburner:feedburnerHostname><item>
			<title>Alternative route for cell death revealed by scientists</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/zha4Vn9YxSE/160303133003.htm</link>
			<description>A new pathway for mitochondrial cell death that involves the protein BCL-2 ovarian killer otherwise known as BOK has been revealed by scientists. The discovery may lead to new ways to trigger cell death in some types of cancer cells, they report.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/zha4Vn9YxSE" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 03 Mar 2016 13:30:03 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160303133003.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160303133003.htm</feedburner:origLink></item>
		<item>
			<title>New report finds 'surprising gaps' in knowledge of ovarian cancers</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/8wMUsj3koSU/160302121241.htm</link>
			<description>Ovarian cancer should not be categorized as a single disease, but rather as a constellation of different cancers involving the ovary, yet questions remain on how and where various ovarian cancers arise, says a new congressionally mandated report.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/8wMUsj3koSU" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 02 Mar 2016 12:12:41 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160302121241.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160302121241.htm</feedburner:origLink></item>
		<item>
			<title>Research on treatments for advanced ovarian cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/kxosJtFr7yU/160226173202.htm</link>
			<description>New research supports the use of weekly chemotherapy without bevacizumab in treating advanced ovarian cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/kxosJtFr7yU" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 26 Feb 2016 17:32:02 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160226173202.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160226173202.htm</feedburner:origLink></item>
		<item>
			<title>Pairing pain medicine with metal ions to battle cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/jULf5cz2ono/160217130711.htm</link>
			<description>Fighting chemoresistant cancer remains a huge challenge that scientists are tackling from as many angles as they can. One alternative approach involves pairing two groups of compounds -- pain medicine and metal ions -- that have individually shown promise as anti-cancer agents. Scientists now report that combining the two led to new compounds that could destroy drug-resistant cancer cells and leave most normal cells alone in lab tests.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/jULf5cz2ono" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 17 Feb 2016 13:07:11 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160217130711.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160217130711.htm</feedburner:origLink></item>
		<item>
			<title>How a master regulator in ovarian cancer can go from helpful to harmful</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/OL6GAw5Xbsk/160211140436.htm</link>
			<description>Scientists have defined the role of how a master genomic organizer influences the behavior of these ovarian-associated dendritic cells, revealing a previously unseen way in which cancer is able to manipulate our immune system.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/OL6GAw5Xbsk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 11 Feb 2016 14:04:36 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160211140436.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160211140436.htm</feedburner:origLink></item>
		<item>
			<title>Research uncovers more inherited genetic mutations linked to ovarian cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/WKC8I3LC_yQ/160210135406.htm</link>
			<description>Previous research has established a link between genetic mutations in the BRCA1 and BRCA2 genes to an increased risk of developing ovarian, fallopian tube or peritoneal cancer in women. A recent publication documents the efforts of a team of researchers to determine if inherited genetic mutations other than BRCA1 and BRCA2 can also put a woman at risk of developing these diseases.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/WKC8I3LC_yQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 10 Feb 2016 13:54:06 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160210135406.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160210135406.htm</feedburner:origLink></item>
		<item>
			<title>Preventive surgery for women at high risk of breast, ovarian cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/zUTGYWOO9Ks/160203184119.htm</link>
			<description>A new article provides an in-depth look at the issues associated with the care of women in families with hereditary breast and ovarian cancer syndrome who have not yet developed cancer themselves.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/zUTGYWOO9Ks" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 03 Feb 2016 18:41:19 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160203184119.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160203184119.htm</feedburner:origLink></item>
		<item>
			<title>Sparing ovaries, removing fallopian tubes may cut cancer risk, but few have procedure</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/nnxnQfUGxA4/160201141913.htm</link>
			<description>During hysterectomies for non-cancerous conditions, removing both fallopian tubes while keeping the ovaries may help protect against ovarian cancer and preserve hormonal levels, but few women receive this surgical option, according to a new study.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/nnxnQfUGxA4" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 01 Feb 2016 14:19:13 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160201141913.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160201141913.htm</feedburner:origLink></item>
		<item>
			<title>Up to 50 percent of women with advanced-stage ovarian cancer could be cured with one treatment model, expert argues</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/vlgblnb9ZHE/160120115743.htm</link>
			<description>Up to half of women with advanced-stage ovarian cancer might be cured, compared to the current 20 percent survival rate, argues a scientist, who calls for a new standard of treatment for women with late-stage ovarian cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/vlgblnb9ZHE" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 20 Jan 2016 11:57:43 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160120115743.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160120115743.htm</feedburner:origLink></item>
		<item>
			<title>A new method to improve the pre-operative diagnosis of ovarian cancer based on ultrasound</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/GsGNt5EGam0/160119073622.htm</link>
			<description>In a landmark study, investigators from Europe propose a new and simple method to assess the risk of malignancy of women with an adnexal mass. The method identified between 89-99 percent of patients with ovarian cancer using the results of ultrasound examination, which can be obtained in referral and non-referral centers. The work is based on the 'Simple Rules' criteria developed by the International Ovarian Tumor Analysis group to improve accurate diagnosis of ovarian cancer before surgery.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/GsGNt5EGam0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 19 Jan 2016 07:36:22 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160119073622.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160119073622.htm</feedburner:origLink></item>
		<item>
			<title>New gene fault behind ovarian cancer found by scientists</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/QNK06kiXO0c/160118224253.htm</link>
			<description>Women who carry an inherited fault in the gene BRIP1 are over three times more likely to develop ovarian cancer than those without the fault, according to a new study. Around 18 women in every 1,000 develop ovarian cancer, but this risk increases to around 58 women in every 1,000 for women with a fault in the BRIP1 gene.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/QNK06kiXO0c" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 18 Jan 2016 22:42:53 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160118224253.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160118224253.htm</feedburner:origLink></item>
		<item>
			<title>New findings may enhance PARP inhibitors therapy in breast cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/UhKiwuJTyMs/160118134538.htm</link>
			<description>PARP inhibitors, an emerging class of drugs being studied in cancer clinical trials, may be enhanced by combining them with inhibitors targeting an oncogene known as c-MET which is overexpressed in many cancers, new research shows.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/UhKiwuJTyMs" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 18 Jan 2016 13:45:38 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160118134538.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160118134538.htm</feedburner:origLink></item>
		<item>
			<title>BRCA1 deficiency increases sensitivity of ovarian cancer cells to auranofin</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/6D5uR9Bc698/160108134332.htm</link>
			<description>An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study has found. Auranofin is currently undergoing trials for repurposing to treat recurrent epithelial ovarian cancer, which makes up around 90 per cent of diagnosed ovarian cancers.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/6D5uR9Bc698" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 08 Jan 2016 13:43:32 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160108134332.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160108134332.htm</feedburner:origLink></item>
		<item>
			<title>Scientists test new strategy that could help fight ovarian cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/Xn9bUygGy4I/160106220518.htm</link>
			<description>A promising novel method to treat gynecologic tumors has been discovered by researchers. The approach focuses on a protein called p53, which is commonly mutated in women who have high-grade serous ovarian cancer, the deadliest form of reproductive cancer. In many women with the disease, the cancer is very advanced by the time it is diagnosed and is therefore difficult to treat.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/Xn9bUygGy4I" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/01/160106220518.jpg" height="177" width="300" />
			<pubDate>Wed, 06 Jan 2016 22:05:18 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160106220518.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160106220518.htm</feedburner:origLink></item>
		<item>
			<title>Long-term outcomes of preventing premature menopause during chemotherapy</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/nMNjwZayNEs/151222163102.htm</link>
			<description>Compared with receiving chemotherapy alone, women with breast cancer who also received the hormonal drug triptorelin to achieve ovarian suppression had a higher long-term probability of ovarian function recovery, without a statistically significant difference in pregnancy rate or disease-free survival, according to a study.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/nMNjwZayNEs" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 22 Dec 2015 16:31:02 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151222163102.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151222163102.htm</feedburner:origLink></item>
		<item>
			<title>Largest ever ovarian cancer trial suggests that screening reduces mortality, but longer follow-up is needed</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/IDZ4sTrxfnM/151217081426.htm</link>
			<description>One of the largest ever randomised trials has concluded that ovarian cancer screening may reduce ovarian cancer mortality by an estimated 20% after follow up of up to 14 years. Longer follow-up is needed to determine the ultimate mortality reduction and if screening the general population is cost effective.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/IDZ4sTrxfnM" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 17 Dec 2015 08:14:26 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151217081426.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151217081426.htm</feedburner:origLink></item>
		<item>
			<title>Newer cancer drug may help protect kidneys from damage caused by older drug</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/AglIKOzAd5s/151215122403.htm</link>
			<description>A class of drugs used increasingly to help fight cancer may have the additional benefit of protecting the kidneys when packaged with the powerful chemotherapy agent cisplatin.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/AglIKOzAd5s" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2015/12/151215122403.jpg" height="169" width="300" />
			<pubDate>Tue, 15 Dec 2015 12:24:03 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151215122403.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151215122403.htm</feedburner:origLink></item>
		<item>
			<title>Fallopian tube organoids promise better understanding of ovarian cancer, infertility</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/fhzVpGnI5cM/151211124256.htm</link>
			<description>A new way of growing fallopian tube cells in culture is expected to give a boost to our understanding and prevention of female genital diseases, such as infertility, inflammatory disease, and ovarian cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/fhzVpGnI5cM" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2015/12/151211124256.jpg" height="248" width="300" />
			<pubDate>Fri, 11 Dec 2015 12:42:56 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151211124256.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151211124256.htm</feedburner:origLink></item>
		<item>
			<title>Obesity contributes to metastasis in ovarian cancer patients</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/u-YEWMSnvus/151207163950.htm</link>
			<description>An increased body mass index is associated with a greater risk for ovarian cancer with worse overall survival, a large number of studies have shown. However, the influence of obesity on ovarian cancer metastasis had not been evaluated. Researchers set out to determine whether obesity contributes to ovarian cancer metastatic success. In other words, are tumor cells better able to successfully metastasize when the "host" is obese versus lean?&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/u-YEWMSnvus" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 07 Dec 2015 16:39:50 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151207163950.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151207163950.htm</feedburner:origLink></item>
		<item>
			<title>Loss of enzyme promotes tumor progression in endometrial cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/2QH5NA3khOA/151207163944.htm</link>
			<description>Scientists have shown for the first time why loss of the enzyme CD73 in human cancer promotes tumor progression. CD73 is the crucial enzyme for generating adenosine, a signaling molecule important for regulation of normal tissue function and stability or homeostasis.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/2QH5NA3khOA" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 07 Dec 2015 16:39:44 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151207163944.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151207163944.htm</feedburner:origLink></item>
		<item>
			<title>Ovarian follicles used to preserve fertility</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/cnkzM01emz8/151203081226.htm</link>
			<description>A potential new approach to fertility preservation for young cancer patients has been discovered, which addresses concerns about beginning cancer treatment immediately and the possibility of reintroducing cancer cells during the fertility preservation process.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/cnkzM01emz8" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 03 Dec 2015 08:12:26 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151203081226.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151203081226.htm</feedburner:origLink></item>
		<item>
			<title>Stopping ovarian cancer in its tracks: Antibody may help patients heal themselves</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/Otdh7Dcj5LE/151201114755.htm</link>
			<description>In a first, researchers show the potential a PD-1 antibody, nivolumab, has in fighting the disease. Nivolumab, an inhibitory antibody for PD-1, has shown efficacy in several types of malignancies including melanoma, kidney cancer, and non-small cell lung cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/Otdh7Dcj5LE" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2015/12/151201114755.jpg" height="180" width="300" />
			<pubDate>Tue, 01 Dec 2015 11:47:55 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151201114755.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151201114755.htm</feedburner:origLink></item>
		<item>
			<title>Insights to how ovarian cancer grows, and potential to stop it</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/AH7FyJiXqMU/151130152209.htm</link>
			<description>Can any cancer cell form another tumor, or is it only select cancer stem cells that give rise to new cancer cells? The answer, a new study finds, is both.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/AH7FyJiXqMU" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 30 Nov 2015 15:22:09 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151130152209.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151130152209.htm</feedburner:origLink></item>
		<item>
			<title>Circulating small cell lung cancer cells successfully cultivated for the very first time</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/CHOgxkpLhz0/151119103547.htm</link>
			<description>Most cases of small cell lung cancer are only diagnosed after the tumor has already formed metastases. Until now it has not been possible to investigate the reasons for this rapid metastasis, because of a lack of sufficient tumor material from patients. Now, the group of researchers has succeeded in creating infinitely reproducing tissue cultures.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/CHOgxkpLhz0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 19 Nov 2015 10:35:47 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151119103547.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151119103547.htm</feedburner:origLink></item>
		<item>
			<title>Researchers find experimental drug can help fight debilitating side effect of ovarian cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/2R3w-LQG1cw/151117093325.htm</link>
			<description>Women who have ovarian cancer often develop a condition called ascites, which is a buildup of fluids in the abdomen. A drug that inhibits a receptor called the Colony-Stimulating-Factor-1 Receptor, or CSF1R, reduces ascites with minimal side effects, new research shows.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/2R3w-LQG1cw" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 17 Nov 2015 09:33:25 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151117093325.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151117093325.htm</feedburner:origLink></item>
		<item>
			<title>Healthy diet may reduce risk of ovarian cancer in African-American women</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/sRhze8M8hWA/151113105614.htm</link>
			<description>A healthy diet may reduce the risk of ovarian cancer in African-American women, according to new data.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/sRhze8M8hWA" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 13 Nov 2015 10:56:14 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151113105614.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151113105614.htm</feedburner:origLink></item>
		<item>
			<title>Previous oral contraceptive use associated with better outcomes in patients with ovarian cancer, study finds</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/Uigiq1sUApc/151111092651.htm</link>
			<description>Patients who develop ovarian cancer appear to have better outcomes if they have a history of oral contraceptive use, according to a study.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/Uigiq1sUApc" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 11 Nov 2015 09:26:51 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151111092651.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151111092651.htm</feedburner:origLink></item>
		<item>
			<title>New method enables the early detection of ovarian cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/0aByW4PXgM8/151110082548.htm</link>
			<description>Around 75 per cent of ovarian tumors arise from the fallopian tube. There are currently no options for detecting this condition early or preventing it. With the help of an innovative, "three-way" catheter, a new study suggests that this situation may be different in the future.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/0aByW4PXgM8" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 10 Nov 2015 08:25:48 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151110082548.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151110082548.htm</feedburner:origLink></item>
		<item>
			<title>Scientists discover genetic mechanism essential to ovary development</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/7b7gH3FyZYA/151105152114.htm</link>
			<description>Scientists have announced a discovery that is expected to allow doctors to diagnose a disease causing infertility and lack of puberty in women, with implications for the development of future treatment options. The characterization of the Nup107 gene and discovering its function in ovarian development will provide a greater understanding of how signaling between the cytoplasm and the nucleus is uniquely involved in ovarian development.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/7b7gH3FyZYA" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2015/11/151105152114.jpg" height="199" width="300" />
			<pubDate>Thu, 05 Nov 2015 15:21:14 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151105152114.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151105152114.htm</feedburner:origLink></item>
		<item>
			<title>CK5 marks cisplatin-resistant ovarian cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/W_V43SLJ9gI/151104133259.htm</link>
			<description>Protein cytokeratin 5 (CK5), known to be a marker of poor prognosis in breast cancer, also marks ovarian cancers likely to be resistant to the common chemotherapy cisplatin, new research confirms.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/W_V43SLJ9gI" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 04 Nov 2015 13:32:59 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151104133259.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151104133259.htm</feedburner:origLink></item>
		<item>
			<title>Different types of ovarian cancer have different causes</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/ge6d8P5pKCA/151102222517.htm</link>
			<description>The more children a woman has or whether a woman has had her fallopian tubes cut lowers the risk of different types of ovarian cancer to different levels, according to new research.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/ge6d8P5pKCA" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 02 Nov 2015 22:25:17 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151102222517.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151102222517.htm</feedburner:origLink></item>
		<item>
			<title>Cancer cells hijack glucose, alter immune cells</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/vjfQBoD5178/151102125723.htm</link>
			<description>When cancer cells compete with immune cells for glucose, the cancer wins. As a result, the immune T cells are not healthy and don't have the weapons to kill the cancer. New research findings, report scientists, have potential as a tool to predict ovarian cancer survival, or a marker to predict effectiveness of immune therapy including checkpoint blockade or immune vaccination.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/vjfQBoD5178" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 02 Nov 2015 12:57:23 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151102125723.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151102125723.htm</feedburner:origLink></item>
		<item>
			<title>Targeted therapy for gastric cancer possible</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/wgbdCg4kcqY/151029102510.htm</link>
			<description>Gastric cancer, otherwise known as stomach cancer, does not respond well to existing treatments and it is currently the third leading cause of cancer death in the world (after lung and liver cancer). Researchers have discovered that certain drugs, currently used to treat breast, ovarian and pancreatic cancers, could also be used to treat certain gastric cancers with a particular pattern of mutations (genomic molecular fingerprint).&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/wgbdCg4kcqY" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 29 Oct 2015 10:25:10 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151029102510.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151029102510.htm</feedburner:origLink></item>
		<item>
			<title>Novel nanoparticles for image-guided phototherapy could improve ovarian cancer treatments</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/ZVOAHkcWsZE/151029093630.htm</link>
			<description>Scientists are investigating a biodegradable nanomedicine that can selectively destroy ovarian cancer cells left behind after surgery. These findings are a step forward in the development of targeted therapies for hard-to-treat cancers.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/ZVOAHkcWsZE" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 29 Oct 2015 09:36:30 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151029093630.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151029093630.htm</feedburner:origLink></item>
		<item>
			<title>Mechanism discovered that could lead to better ovarian cancer treatment</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/mHWy_p8AcyE/151026132314.htm</link>
			<description>Resistance to chemotherapy is a major problem for those suffering from ovarian cancer -- a problem that prevents a cure from a disease dubbed the 'silent killer.' Now researchers are giving patients new hope with recent findings that help pinpoint the mechanisms causing chemoresistance.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/mHWy_p8AcyE" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 26 Oct 2015 13:23:14 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151026132314.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151026132314.htm</feedburner:origLink></item>
		<item>
			<title>Research explains limits of cancer immunotherapy drugs</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/NCHcBhhNNXk/151026125028.htm</link>
			<description>Molecular changes within a tumor have been revealed by a team of scientists that suggests that they are are preventing immunotherapy drugs from killing off the cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/NCHcBhhNNXk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 26 Oct 2015 12:50:28 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151026125028.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151026125028.htm</feedburner:origLink></item>
		<item>
			<title>Breast, ovarian cancer risk may have association with sense of smell</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/tQedofTvqKs/151021144702.htm</link>
			<description>For the first time, researchers have noted that the estrous cycle (the equivalent of human menstrual cycle) in mice carrying a mutation known to cause familial predisposition to breast and ovarian cancer in humans is more readily stimulated by scent than in normal mice. Even more surprising was the finding that the ovary, independently of the nose, mediated the olfactory signals.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/tQedofTvqKs" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 21 Oct 2015 14:47:02 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151021144702.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151021144702.htm</feedburner:origLink></item>
		<item>
			<title>Special class of T cells shown to both attack cancer cells and enlist other immune cells</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/vUyfFTuAWj4/151015120316.htm</link>
			<description>New insights about a subset of T cells has been shared by researchers, that suggest that they appear to both inhibit cancer growth and enhance the tumor-killing powers of other immune cells.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/vUyfFTuAWj4" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 15 Oct 2015 12:03:16 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151015120316.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151015120316.htm</feedburner:origLink></item>
		<item>
			<title>New research shows ovarian transplants appear to be safe, effective</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/5DiKijrBBIw/151006192457.htm</link>
			<description>Women who have ovarian tissue removed, stored and then transplanted back to them at a later date have a good chance of successfully becoming pregnant, according to a review of the largest series of ovarian transplants performed worldwide.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/5DiKijrBBIw" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 06 Oct 2015 19:24:57 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151006192457.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151006192457.htm</feedburner:origLink></item>
		<item>
			<title>Treatment-free intervals in ovarian cancer not linked to initial response</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/xDZc_CInWmc/150930150121.htm</link>
			<description>Three-quarters of women treated for ovarian cancer face relapse of their disease. And while those who respond well to initial therapy do tend to survive longer, they require additional treatment for recurring cancer just as frequently as other women whose initial treatment response was not so pronounced. This is a key conclusion of new research that contributes new information about the dynamics of recurrent ovarian cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/xDZc_CInWmc" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 30 Sep 2015 15:01:21 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/09/150930150121.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/09/150930150121.htm</feedburner:origLink></item>
		<item>
			<title>Sniffing out cancer with improved 'electronic nose' sensors</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/9qmG21-D084/150930092513.htm</link>
			<description>Scientists have been exploring new ways to 'smell' signs of cancer by analyzing what's in patients' breath. In a new study, one team now reports new progress toward this goal. The researchers have developed a small array of flexible sensors, which accurately detect compounds in breath samples that are specific to ovarian cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/9qmG21-D084" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2015/09/150930092513.jpg" height="308" width="300" />
			<pubDate>Wed, 30 Sep 2015 09:25:13 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/09/150930092513.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/09/150930092513.htm</feedburner:origLink></item>
		<item>
			<title>Hormone replacement therapy safe, perhaps beneficial in women treated for ovarian cancer, major trial shows</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/rfBang4coSk/150928182126.htm</link>
			<description>Women with the most common type of ovarian cancer can safely take hormone replacement therapy (HRT), and it could have a beneficial effect on their survival, a long-term clinical trial reports. The 24-year, phase III international trial provides the strongest evidence yet that women with epithelial ovarian cancer -- which accounts for 80-90 per cent of cases -- can safely take HRT during or after their treatment.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/rfBang4coSk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 28 Sep 2015 18:21:26 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/09/150928182126.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/09/150928182126.htm</feedburner:origLink></item>
		<item>
			<title>Number of cancer gene tests increases five-fold thanks to improved availability: making prevention easier</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/ZqJpG6dHLAU/150928082406.htm</link>
			<description>Mutations in the BRCA 1 and BRCA 2 genes are very likely to lead to a form of cancer in people who have them. These mutations can be detected using a genetic test. The introduction of a new drug has improved treatment options and this, coupled with increased awareness and improved access, increased the number of genetic tests carried out at one hospital last year by a factor of five. As a result, more at-risk patients are picked up and early prevention measures can be commenced.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/ZqJpG6dHLAU" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 28 Sep 2015 08:24:06 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/09/150928082406.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/09/150928082406.htm</feedburner:origLink></item>
		<item>
			<title>Researchers isolate possible ovarian cancer biomarkers</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/O1Uh_TE1mXE/150916184915.htm</link>
			<description>Researchers have utilized a highly sensitive mass spectrometry analysis to identify and measure difficult-to-detect N-glycan biomarkers associated with ovarian cancers in stages I-IV. In a surprising finding, the researchers determined that the level of biomarkers associated with ovarian cancer does not simply increase or decrease over the course of the disease, but can rise and fall during different stages.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/O1Uh_TE1mXE" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 16 Sep 2015 18:49:15 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/09/150916184915.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/09/150916184915.htm</feedburner:origLink></item>
		<item>
			<title>Cancer preventative surgery could become a thing of the past, new research suggests</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/esCH2TLHDis/150910091406.htm</link>
			<description>Two new studies looking at the effect the menstrual cycle has on the development of breast and ovarian cancer reveal alternative prevention strategies that may render surgery unnecessary.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/esCH2TLHDis" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 10 Sep 2015 09:14:06 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/09/150910091406.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/09/150910091406.htm</feedburner:origLink></item>
		<item>
			<title>Inducing metabolic catastrophe in cancer cells</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/yla7JZ2pMI0/150831101507.htm</link>
			<description>Cancer cells survive the stressful environment inside a tumor in part through autophagy, the controlled digestion and recycling of damaged components. However, blocking the process doesn't kill cancer cells, so researchers have been looking for a way to make cells vulnerable to autophagy shutdown. Researchers now describe a way to force cancer cells to destroy a key metabolic enzyme they need to survive.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/yla7JZ2pMI0" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2015/08/150831101507.jpg" height="299" width="300" />
			<pubDate>Mon, 31 Aug 2015 10:15:07 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/08/150831101507.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/08/150831101507.htm</feedburner:origLink></item>
		<item>
			<title>Advance in photodynamic therapy offers new approach to ovarian cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/EwYpDMREPww/150813142721.htm</link>
			<description>Researchers have made a significant advance in the use of photodynamic therapy to combat ovarian cancer in laboratory animals, using a combination of techniques that achieved complete cancer cell elimination with no regrowth of tumors.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/EwYpDMREPww" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 13 Aug 2015 14:27:21 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/08/150813142721.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/08/150813142721.htm</feedburner:origLink></item>
		<item>
			<title>Multigene panel testing for hereditary breast/ovarian cancer risk assessment</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/mJossrPC_Fc/150813123035.htm</link>
			<description>Multigene testing of women negative for BRCA1 and BRCA2 found some of them harbored other harmful genetic mutations, most commonly moderate-risk breast and ovarian cancer genes and Lynch syndrome genes, which increase ovarian cancer risk, according to an article.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/mJossrPC_Fc" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 13 Aug 2015 12:30:35 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/08/150813123035.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/08/150813123035.htm</feedburner:origLink></item>
		<item>
			<title>Long-term ovarian cancer survival higher than thought</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/y00q6nFSVOM/150806102223.htm</link>
			<description>Combing data collected on thousands of California ovarian cancer patients, researchers have determined that almost one-third survived at least 10 years after diagnosis.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/y00q6nFSVOM" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 06 Aug 2015 10:22:23 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/08/150806102223.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/08/150806102223.htm</feedburner:origLink></item>
		<item>
			<title>Combination therapy may be more effective against the most common ovarian cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/LDGix3gtUvc/150803083712.htm</link>
			<description>High-grade serous ovarian cancer often responds well to the chemotherapy drug carboplatin, but why it so frequently comes back after treatment has been a medical mystery. Now a team of researchers has discovered that a subset of tumor cells that donât produce the protein CA125, a biomarker used to test for ovarian cancer, has an enhanced ability to repair their DNA and resist programmed cell death â which allows the cells to evade the drug and live long enough to regrow the original tumor.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/LDGix3gtUvc" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 03 Aug 2015 08:37:12 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/08/150803083712.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/08/150803083712.htm</feedburner:origLink></item>
		<item>
			<title>Anti-inflammatory drug acts against ovarian cancer, scientists find</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/pBSE5GGhj1E/150728123717.htm</link>
			<description>A non-steroidal anti-inflammatory drug (NSAID) called ketorolac helped women with ovarian cancer to survive longer, researchers report. Ketorolac, marketed as ToradolÂ®, is approved for clinical use in the United States for pain after surgery.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/pBSE5GGhj1E" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 28 Jul 2015 12:37:17 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/07/150728123717.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/07/150728123717.htm</feedburner:origLink></item>
		<item>
			<title>Gene therapy may improve survival of patients with recurrent ovarian cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/KLS4075sMOk/150727153729.htm</link>
			<description>Use of gene therapy to deliver a protein that suppresses the development of female reproductive organs may improve the survival of patients with ovarian cancer that has recurred after chemotherapy, which happens 70 percent of the time and is invariably fatal.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/KLS4075sMOk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 27 Jul 2015 15:37:29 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/07/150727153729.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/07/150727153729.htm</feedburner:origLink></item>
		<item>
			<title>Important molecule in ovarian cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/FEiEpqnz4bM/150722101841.htm</link>
			<description>An important new target for ovarian cancer therapy has been identified by scientists. Contrary to current research, this new study found that LKB1 is an important molecule in the cancer's promotion and survival. Their research definitively shows that ovarian cancer cells still have LKB1 and that this molecule allows ovarian cancer spheroids to change their metabolism, promote tumor cell survival and make them more resistant to chemotherapy.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/FEiEpqnz4bM" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 22 Jul 2015 10:18:41 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/07/150722101841.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/07/150722101841.htm</feedburner:origLink></item>
		<item>
			<title>Scientists solve breast, ovarian cancer genetic mystery</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/DgbGWH6UtHk/150716123848.htm</link>
			<description>Scientists have solved a decades-old mystery and helped to unravel the genetic cause of some breast and ovarian cancers, according to new research. Following a five-year study in nematode worms, researchers have uncovered how key proteins can switch on a protein called RAD51, allowing it to repair cancer-causing DNA damage in cells.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/DgbGWH6UtHk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 16 Jul 2015 12:38:48 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/07/150716123848.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/07/150716123848.htm</feedburner:origLink></item>
		<item>
			<title>Leisure time sitting linked to higher risk of specific cancers</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/e6CZUdyYX5I/150713131429.htm</link>
			<description>Spending more leisure time sitting was associated with a higher risk of total cancer risk in women, and specifically with multiple myeloma, breast, and ovarian cancers, according a new study.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/e6CZUdyYX5I" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 13 Jul 2015 13:14:29 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/07/150713131429.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/07/150713131429.htm</feedburner:origLink></item>
		<item>
			<title>New drug combo could make cancer more sensitive to chemo</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/6kMuotTet1w/150713131343.htm</link>
			<description>Combining chemotherapy with new drugs that target a protein that helps cancer cells to withstand chemotherapy could drastically improve treatment, according to new research.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/6kMuotTet1w" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 13 Jul 2015 13:13:43 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/07/150713131343.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/07/150713131343.htm</feedburner:origLink></item>
		<item>
			<title>Cancer drug 49 times more potent than Cisplatin</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/t2X9ADPunDg/150707092414.htm</link>
			<description>A new cancer drug has been found to have effectiveness for ovarian and bowel cancer that is 49 times as potent is Cisplatin. The key to this new drug, researchers report, is that it can shut down a cancer cell's metabolism. They add that the new drug could be cheaper to produce and less harm to healthy cells than alternative therapies.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/t2X9ADPunDg" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 07 Jul 2015 09:24:14 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/07/150707092414.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/07/150707092414.htm</feedburner:origLink></item>
		<item>
			<title>Body mass index impacts ovarian cancer chemotherapy dosages</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/avGqXqtagpY/150702112127.htm</link>
			<description>Ovarian cancer patients who are overweight or obese are often given less chemotherapy per pound of body weight in order to reduce the toxic side effects associated with higher doses, and this in turn may lower their chances of survival, according to a new study.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/avGqXqtagpY" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 02 Jul 2015 11:21:27 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/07/150702112127.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/07/150702112127.htm</feedburner:origLink></item>
		<item>
			<title>Experimental drug combined with standard chemo may shrink treatment-resistant ovarian cancers, animal study shows</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/izQ84grbm8I/150701094510.htm</link>
			<description>Working in cell cultures and mice, researchers have found that an experimental drug called fostamatinib combined with the chemotherapy drug paclitaxel may overcome ovarian cancer cells' resistance to paclitaxel.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/izQ84grbm8I" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 01 Jul 2015 09:45:10 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/07/150701094510.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/07/150701094510.htm</feedburner:origLink></item>
		<item>
			<title>New class of compounds shrinks pancreatic cancer tumors, prevents regrowth</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/ovarian_cancer/~3/2JNz-7_lOFU/150625125958.htm</link>
			<description>A chemical compound that has reduced the growth of pancreatic cancer tumors by 80 percent in treated mice has been developed by researchers. The compound, called MM41, was designed to block faulty genes. It appears to do this by targeting little knots in their DNA, called quadruplexes, which are very different from normal DNA and which are especially found in faulty genes.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/ovarian_cancer/~4/2JNz-7_lOFU" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2015/06/150625125958.jpg" height="207" width="300" />
			<pubDate>Thu, 25 Jun 2015 12:59:58 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/06/150625125958.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/06/150625125958.htm</feedburner:origLink></item>
	</channel>
</rss><!-- Page successfully written to cache. --><!-- cached Sun, 06 Mar 2016 23:07:01 EST -->
